Skip to content
Home/Companies/MedTech/Advosense
Advosense

Advosense

MedTech·Germany·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns Advosense?

Advosense is currently owned by Gruenderfonds Ruhr through Gruenderfonds Ruhr I (2017 vintage), since 2020.

Hand-verified · updated 2026-07-03

Gruenderfonds Ruhr
Investor
Gruenderfonds Ruhr
Gruenderfonds Ruhr I · 2017 · VC

Key facts

HQGermany
SectorMedTech
StatusActive
Websitewww.advosense.com

More from Gruenderfonds Ruhr I

Other portfolio companies in the same fund.

Lidrotec
Active
IndustrialsGermany· 2022
Spherity
Spherity
Active
CybersecurityGermany· 2022
VMRay
VMRay
Active
CybersecurityGermany· 2022
Masterplan
Masterplan
Exited 2025
SoftwareGermany· 2020
to
Abalos Therapeutics
Active
BiotechGermany· 2019
DIMATE
Dimate
Active
IndustrialsGermany· 2019

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track Advosense

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Advosense?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Advosense.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue